Roche Receives FDA Breakthrough Label for AI-Powered Lung Cancer Companion Diagnostic Test

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial-intelligence-powered analysis to provide what the company says could become the agency’s first AI-driven companion diagnostic for NSCLC.